© 2021 MJH Life Sciences™ and Opthalmology Times Europe. All rights reserved.
Cornea
Towards a customised treatment of patients with keratoconic eyes
September 01, 2019
Immune mechanisms in allergic eye disease
February 26, 2018
Ocular allergy affects the quality of life of millions of people every year. Understanding the different mechanisms involved will increase their future therapeutic options.
Cellular therapy of the corneal stroma: Real approach or science fiction?
January 08, 2018
The first human clinical trial to preliminarily evaluate the safety and efficacy of cellular therapy with mesenchymal stem cells for the corneal stroma has shown promise.
Angiography within anterior imaging
December 01, 2017
It is important with corneal angiography to remember that every patient is different so your technique might very slightly from patient to patient.
Cenegermin receives European Commission marketing authorization
August 30, 2017
The European Commission has granted marketing authorisation for cenegermin eye drops (Oxervate, Dompé) for the treatment of moderate to severe neurotrophic keratitis.
Numbers transform dry eye treatment for symptomatic, asymptomatic patients
August 09, 2017
Adding objective point-of-care dry eye diagnostics to your practice has deep, measurable effects, including more accurate and consistent IOL power calculations.
EMA committee recommends cenegermin for neurotrophic keratitis
May 31, 2017
A committee of the European Medicines Agency has recommended approval of cenegermin (Oxervate, Dompé) eye drops for neurotrophic keratitis.
Rituximab appears to cure Mooren’s ulcers in 5 patients
May 03, 2017
Mooren’s ulcers completely healed in 5 patients treated with rituximab after conventional treatment failed, according to researchers.
Patients’ health jeopardized by failed ophthalmology follow-up
March 29, 2017
Failure to follow-up after ophthalmology appointments can damage patients’ health, a new study suggests. “In our view, national consideration should be given to create targets for reporting how well providers are managing follow-up patients,” reported A Davis and colleagues in the journal Eye.